ID Part 1 Flashcards
Which of the following statements is correct regarding ceftriaxone?
A. It should be given with IV calcium in neonates.
B. It displays concentration-dependent bactericidal activity.
C. It has better Gram-negative activity than cefotetan.
D. It is available in both oral and intravenous formulations.
E. It requires dose adjustment in renal dysfunction.
It has better Gram-negative activity than cefotetan.
Ceftriaxone is a 3rd generation cephalosporin that has broader Gram-negative activity than the 2nd generation cephalosporins (e.g., cefotetan).
Similar to all beta-lactams, it displays time-dependent bacterial killing.
Ceftriaxone is only available IV and does not require dose adjustment in renal dysfunction.
Ceftriaxone is contraindicated in neonates (causes biliary sludging, kernicterus) and concurrent use with IV calcium in neonates is contraindicated.
Cephalosporins
1st Generation
Meds & Coverage
IV: Cefazolin (Ancef), PO: Cephalexin (Keflex), cefadroxil (Duricef)
Staphylococci (MSSA), Streptococci, PEK, mouth anaerobes (Peptostreptococci)
Which generation cephalosporins is preferred for MSSA?
1st Gen
Cephalosporins
1st Generation Uses
Inpatient
Cefazolin (Ancef)
Surgical PPx
Cephalosporins
1st Generation Uses
Outpatient
Cephalexin (Keflex)
Strep throat, MSSA skin infections
Cephalosporins
2nd Generation
Meds & Coverage
IV/IM/PO: Cefuroxime (Ceftin, Zinacef)
Staphylococci
Better Gram-negative activity (HNPEK) than 1st gen
IV/IM Cefotetan (Cefotan) and Cefoxitin (Mefoxin)
Additional gram (-) anaerobic activity (B. fragilis)
PO: Cefaclor, Cefprozil (Cefzil)
Cephalosporins
2nd Generation
Inpatient
Cefotetan (Cefotan) and Cefoxitin (Mefoxin)
Surgical PPx (GI procedures)
Anaerobic activity (B. fragilis)
Which cephalosporin has a disulfiram-like reaction?
Cefotetan (Cefotan)
Cephalosporins
2nd Generation
Outpatient
Cefuroxime (Ceftin)
Acute OM, CAP, sinus infections
Cephalosporins
3rd Generation
Meds & Coverage
Group 1: IV Ceftriaxone, Cefotaxime
PO Cefdinir (Omnicef), Cefixime (Suprax), Cefpodoxime
Resistant Streptococci (S. pneumonaiae & viridans)
Staphylococci (MSSA)
Gram (+) anaerobes
Resistant strains of HNPEK
Group 2: IV Ceftazidime (Fortaz, Tazicef), Ceftazidime/Avibactam (Avycaz)
Lacks gram (+) activity
Pseudomonas
Cephalosporins
3rd Generation Uses
Outpatient
Cefdinir (Omnicef)
CAP, sinus infections
Cephalosporins
3rd Generation Uses
Inpatient
Ceftriaxone, Cefotaxime (Claforan)
CAP, meningitis, spontaneous bacterial perionitis (SBP), pyelonephritis
Which cephalosporin does not required renal adjustment?
Ceftriaxone
Which cephalosporins is not used in neonates?
Ceftriaxone
Cephalosporins
4th Generation
Meds & Coverage
IV: Cefepime (Maxipime)
Broad-spectrum: Gram-positives (similar to ceftriaxone), HNPEK, CAPES, Pseudomonas
Which cephalosporins covers Pseudomonas?
Ceftazidime (Fortaz, Tazicef)
Cefepime (Maxipime)
Ceftolozane/tazobactam (Zerbaxa)
Cefiderocol (Fetroja)
Cephalosporins
5th Generation
Meds & Coverage
IV Ceftaroline (Teflaro),
Gram (-) similar to ceftriaxone
Broad gram (+) MRSA coverage
Cephalosporins combo
Meds & Coverage
ceftazidime/avibactam (Avycaz)
ceftolozane/tazobactam (Zerbaxa)
Similar spectrum to ceftazidime
Added activity against MDR gram (-) rods
Siderophore Cephalosporin
Meds & Coverage
IV cefiderocol (Fetroja)
PEK
Enterobacter
Pseudomonas
What cephalosporin covers MRSA?
Ceftaroline (Teflaro)
Cephalosporins do not cover?
Enterococcus
Atypicals
Cephalosporins Class Effects
Betam-lactam allergy
Risk of seizures
BV is a 42-year-old male who comes to his primary care provider with a 2-day history of new-onset shortness of breath, fever, chills, fatigue, and persistent cough. He has no other health issues and no known drug allergies. A chest x-ray confirms pneumonia. The local antibiogram shows Streptococcus pneumoniae is 60% susceptible to macrolides. What is the most appropriate antibiotic therapy for this patient?
A. Amoxicillin for 10 days
B. Azithromycin for 5 days
C. Azithromycin for 10 days
D. Doxycycline for 5 days
E. Doxycycline for 10 days
Doxycycline for 5 days
The recommended treatment options for outpatient community-acquired pneumonia in healthy patients with no comorbidities include monotherapy with amoxicillin, doxycycline, or a macrolide (if local pneumococcal resistance is less than 25%).
The typical duration of treatment is 5 to 7 days.
Longer durations of treatment offer no benefit and increase the risk of adverse effects.
Community Acquired Pneumonia (CAP) Tx
Outpatient - no comorbidities
Amoxicillin 1 g TID
Doxycycline
Macrolide (azithromycin or clarithromycin)
For 5 to 7 days
Macrolid - only rec in healthy pts if local pneumococcal macrolide resistance is < 25%